Rti surgical, inc (rti) and tutogen medical gmbh (tmi), a wholly subsidiary of rti, received a complaint on (b)(6) 2021.
An adverse event was reported through a post market survey for tutomesh® for breast reconstruction application.
The survey indicated that the dr.
(b)(6) ( 15 years' experience with the product; 10 - 20 cases/year), has experienced the following post-operative complications: implant loss, infections, inflammation and seroma formation in 1 - 5 % of cases; and red breast syndrome in less than 1% of cases.
Additional information has been requested.
To date, no additional information has been received.
|